Monographie - Durvalumab

Poslední aktualizace :
19/11/2024

Durvalumab

Prekinis pavadinimas

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Imfinzi

Didžioji Britanija, Jungtinės Amerikos Valstijos, Kanada, Prancūzija, Šveicarija, Vokietija

Bibliografija : Durvalumab

	tipas	leidinys
4608	Laboratorija	Durvalumab (Imfinzi - Summery of Product Characteristics, updated August 2021) Astra Zeneca 2021
4767	Žurnalas	Almasi K, Thiesen J, Krämer I. Physicochemical stability of durvalumab (Imfinzi® ) concentrate for solution in original vials after first opening. Pharmaceutical Technology in Hospital Pharmacy 2023 ;8,1
4772	Žurnalas	Porlier A, Gagnon P-Y, Chénard V, Michael N-J, Simard C, Drolet B. Stability of Opened Durvalumab (IMFINZI) Vials. The Beginning of the End of Costly Product Wastage? J Pharm Sci 2023 ; 112, 9: 2412-2418.

Mentions Légales